(Q33362766)

English

Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

endometrial carcinoma

1 reference

based on heuristic

inferred from title

gynecologic oncology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

John T Soper

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Susan A Reisinger

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Robert Ashbury

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ellen Jones

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Daniel L Clarke-Pearson

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

95

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

95-100

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A phase II study of Cis-platinum for recurrent corpus cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.041

7 January 2021

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.041

7 January 2021

Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.041

7 January 2021

A phase I study of weekly cisplatin and whole abdominal radiation for the treatment of stage III and IV endometrial carcinoma: a Gynecologic Oncology Group pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.041

7 January 2021

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.041

7 January 2021

Postoperative whole abdomino-pelvic irradiation for patients with high risk endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.041

7 January 2021

The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.041

7 January 2021

Analysis of the cost effectiveness of concurrent cisplatin-based chemoradiation in cervical cancer: implications from five randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.041

7 January 2021

Circadian-timed combination doxorubicin-cisplatin chemotherapy for advanced endometrial carcinoma. A phase II study of the Gynecologic Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.041

7 January 2021

Bone marrow regeneration following large field radiation.Influence of volume, age, dose, and time

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.041

7 January 2021

Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.041

7 January 2021

Treatment of intraperitoneal metastatic adenocarcinoma of the endometrium by the whole-abdomen moving-strip technique and pelvic boost irradiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.06.041

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YGYNO.2004.06.041

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33362766&oldid=1980896314"